The evidence field · updated daily

8,080 peptide studies,
read so you don't have to.

Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from 5 primary sources, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.

4,445 studies dated 2026 alone — the peptide literature is compounding.

Studies by publication year 1998–2026
PubMed Clinical trials Other sources

Where it comes from

  • PubMed 5,683
  • ClinicalTrials.gov 1,959
  • EuropePMC 309
  • DailyMed 82
  • PubChem 47

Evidence strength

  • Strong · trials & meta-analyses 757
  • Moderate · cohorts & reviews 564
  • Early · preclinical & in-vitro 1,819
  1. 2026-07-30 ClinicalTrials.gov

    Pegvisomant Clarifies GH/IGF-I Dependency in Adult GHD Patients with Normal IGF-I Levels

    Clarifying the **GH/IGF-I** relationship in **AGHD** patients with normal **IGF-I** could significantly refine diagnostic criteria and treatment strategies. Currently, a normal `IGF-I` can mask **Adult Growth Hormone Deficiency (AGHD)**,…

  2. 2021-03-20 ClinicalTrials.gov

    Liraglutide plus megestrol acetate combination investigated for efficacy in endometrial atypical hyperplasia

    If proven effective, the combination of **liraglutide** and **megestrol acetate** could offer a significant new therapeutic option for patients with **endometrial atypical hyperplasia (AEH)**, especially those with obesity who often resp…

  3. 2011-07-19 ClinicalTrials.gov

    Liraglutide's safety and effectiveness evaluated in Asian Type 2 Diabetes patients

    **Understanding Liraglutide's safety profile in Asian populations is critical for personalized medicine and global drug development.** This trial contributes to a more complete picture of how `GLP-1R` agonists perform across diverse demo…

  4. 2019-05-28 ClinicalTrials.gov

    Semaglutide's real-world effectiveness in Type 2 Diabetes to be assessed in Dutch clinical practice

    This real-world study is crucial for understanding **semaglutide's** effectiveness beyond controlled clinical trials, offering insights into its performance in diverse patient populations and varied clinical settings. **Clinicians can ga…

  5. 2013-12-02 ClinicalTrials.gov

    Semaglutide Once-Weekly Efficacy and Safety Compared to Sitagliptin Once-Daily in Type 2 Diabetes

    While specific results are not available in this abstract, a trial comparing **semaglutide** and **sitagliptin** as add-on therapy for **Type 2 Diabetes** holds significant clinical importance. **Semaglutide**, a potent `GLP-1R` agonist,…

  6. 2026-07-30 PubMed

    Daily GLP-1 Receptor Agonists Showed Glycemic Efficacy in T1D but Faced Hypoglycemia and Ketosis Safety Issues

    Daily GLP-1 receptor agonists improved T1D glycemic control and weight, but safety issues (hypoglycemia, ketosis) emerged, shifting focus to weekly agents.

  7. 2026-07-30 PubMed

    Weekly GLP-1 Receptor Agonists: Current Knowledge, Gaps, and Future Trials in Type 1 Diabetes

    This review provides crucial guidance for clinicians and individuals with **Type 1 Diabetes (T1D)** considering **GLP-1 Receptor Agonists (GLP-1 RAs)** as an adjunctive therapy. **It clarifies the current state of evidence, helping to ma…

  8. 2026-07-30 PubMed

    GLP-1 Receptor Agonists May Reduce Insulin Requirements in New-Onset Type 1 Diabetes

    **Integrating GLP-1 receptor agonists into early Type 1 Diabetes management could significantly reduce the daily insulin burden and potentially slow the decline of native insulin production.** For individuals with new-onset T1D, this cou…

  9. 2026-07-30 PubMed

    SGLT2 inhibitors, GLP-1RAs, MRBs show emerging cardiorenal protection in Type 1 Diabetes.

    This review marks a significant shift in the management paradigm for **Type 1 Diabetes (T1D)**, emphasizing the importance of cardiorenal protection beyond glycemic control. **Clinicians should now actively consider integrating SGLT2 inh…

  10. 2026-07-30 PubMed

    Emerging Evidence Supports SGLT2 Inhibitors, GLP-1 Receptor Agonists, and MRBs for Cardiorenal Protection in Type 1 Diabetes.

    Review summarizes emerging data on **SGLT2 inhibitors**, **GLP-1 receptor agonists**, and **mineralocorticoid receptor blockers** for **cardiovascular** and **renal protection** in **Type 1 Diabetes**.

  11. 2026-07-30 PubMed

    SGLT2 Inhibitors, Incretin Agonists, and Finerenone Show Promise for Kidney Protection in Type 1 Diabetes

    This comprehensive review signals a significant shift in the management paradigm for **Diabetic Kidney Disease** (**DKD**) in **Type 1 Diabetes** (**T1D**). **Clinicians and patients with T1D should anticipate the broader integration of …

  12. 2026-07-30 PubMed

    Clinical Guidance Outlines Safe GLP-1RA Use, Titration, and Monitoring for Adults with Type 1 Diabetes

    New clinical guidance details safe initiation, titration, and monitoring of GLP-1RAs as adjunctive therapy for adults with Type 1 Diabetes.

  13. 2026-07-30 PubMed

    GLP-1RA and SGLT-1/2 inhibitor combination: a promising adjunctive strategy for Type 1 Diabetes.

    Combining **GLP-1RAs** and **SGLT-1/2 inhibitors** offers a promising adjunctive strategy for **Type 1 Diabetes**, aiming to improve glycemic control and weight.

  14. 2026-07-30 PubMed

    Type 1 Diabetes Patients Prioritize Weight Management, Glycemic Stability, and Reduced Burden in Adjunctive Therapies

    Understanding patient expectations is paramount for the successful development and adoption of new **Type 1 Diabetes** adjunctive therapies. This review highlights that **future therapies must move beyond solely glycemic targets to addre…

  15. 2026-07-30 PubMed

    Antimicrobial Peptides Among Emerging Strategies to Combat Canine MRSP Crisis

    This review signals a crucial paradigm shift in managing **canine MRSP infections**, moving beyond sole reliance on conventional antibiotics. **Veterinarians and pet owners may soon have access to novel adjunct therapies that can improve…

  16. 2026-07-30 PubMed

    Translational Recoding in Tumors: Dual Role in Adaptation and Immune Evasion, Emerging as Therapeutic Target

    This review underscores a fundamental shift in understanding **cancer** biology, revealing how altered protein synthesis contributes to tumor survival and immune evasion. **Targeting translational recoding offers a novel strategy to enha…

  17. 2026-07-30 PubMed

    Type 1 Diabetes management needs agents beyond insulin to address cardiovascular risk and metabolic disturbances

    This review fundamentally shifts the perspective on **Type 1 Diabetes** management, emphasizing that glycemic control alone is insufficient for optimal patient outcomes. **Clinicians and individuals with T1D should consider adjunctive th…

  18. 2026-07-30 PubMed

    Retatrutide's Effects on Learning, Memory, and Neuroinflammation Explored in Diabetic Rats.

    Retatrutide's potential to improve learning and memory in streptozotocin-induced diabetic rats was investigated, assessing neuroinflammatory and neurotrophic markers.

  19. 2026-07-29 PubMed

    Pooling heterogeneous amyloid-beta monoclonal antibodies in reviews obscures distinct clinical effects in Alzheimer's disease.

    **Accurate interpretation of evidence for Alzheimer's disease therapies is paramount for clinical decision-making and patient care.** This perspective highlights a critical methodological concern in systematic reviews of **amyloid-beta m…

  20. 2026-07-29 PubMed

    FOSL2 drives cardiomyocyte PANoptosis and heart failure progression post-AMI by activating NLRP12 transcription

    This research identifies `FOSL2` and `NLRP12` as critical drivers of **PANoptosis** and **heart failure** progression post-`AMI`, offering novel therapeutic targets. **Targeting the FOSL2-NLRP12 axis could provide a new strategy to mitig…

  21. 2026-07-29 ClinicalTrials.gov

    Oxytocin Minimum Effective Dose Trial Aims to Optimize Postpartum Hemorrhage Prevention During Cesarean

    Identifying the **minimum effective dose of oxytocin** for cesareans during labor could significantly improve maternal safety by reducing postpartum hemorrhage while minimizing potential side effects from excessive dosing. This research,…

  22. 2026-05-06 ClinicalTrials.gov

    DWRX5003 safety and relative bioavailability to DWC202502 and DWC202503 evaluated in healthy adults

    DWRX5003's safety and relative bioavailability compared to DWC202502 and DWC202503 were assessed in a Phase 1 trial in healthy adults.

  23. 2026-07-29 PubMed

    Molecular Dynamics Simulations Uncover Conformation-Specific Stability and Flexibility of Baboon Theta-Defensin-2 (BTD-2) Peptides

    Understanding the conformational dynamics of theta-defensins is crucial for the **rational design of next-generation antimicrobial and antiviral therapeutics**. This research highlights that even peptides with similar sequences can exhib…

  24. 2026-07-29 PubMed

    Topical Hyaluronic Acid Accelerates Early Gingival Wound Healing in Rats, Reducing Wound Area by Day 3

    This study suggests that **topical hyaluronic acid could be a valuable, accessible adjunct for accelerating early post-surgical or traumatic gingival wound healing**. For clinicians and individuals seeking to optimize recovery, HA gel mi…

  25. 2026-07-29 PubMed

    Semaglutide initiation unmasks adult annular pancreas, causing gastric outlet obstruction in 55-year-old male

    This case underscores a critical clinical consideration for individuals using `GLP-1 RAs` like **semaglutide**: severe gastrointestinal symptoms should not be automatically attributed to medication side effects. **Clinicians must maintai…

  26. 2026-07-29 PubMed

    Tirzepatide-induced rapid weight loss linked to peroneal nerve palsy from leg crossing in two patients

    This case series highlights a critical, yet often overlooked, adverse event associated with rapid weight loss from **tirzepatide** and similar GLP-1/GIP agonists. **Clinicians prescribing tirzepatide should proactively counsel patients o…

  27. 2026-07-29 ClinicalTrials.gov

    IMC-A12 added to irinotecan and cetuximab evaluated for metastatic colorectal cancer after oxaliplatin and bevacizumab failure

    For patients battling **metastatic colorectal cancer** that has progressed on first-line therapy, new treatment options are desperately needed. **Adding IMC-A12 to irinotecan and cetuximab could offer a crucial second-line strategy**, po…

  28. 2007-10-22 ClinicalTrials.gov

    Randomized Phase III Trial Compares Two Chemotherapy Regimens for Pediatric Brain Tumors Before Stem Cell Transplant

    **Identifying the most effective pre-transplant chemotherapy regimen** for pediatric **PNETs** and **high-risk medulloblastoma** could significantly improve survival rates and reduce long-term sequelae in young patients. If one regimen d…

  29. 2026-07-29 ClinicalTrials.gov

    Theta-burst patterned Temporal Interference Stimulation protocol developed and evaluated in Narcolepsy Type 1 patients

    **Developing noninvasive neuromodulation for deep brain structures like the hypothalamus represents a significant advancement for NT1 treatment.** If effective, this `TI stimulation` could offer a novel therapeutic avenue beyond current …

  30. 2026-07-29 ClinicalTrials.gov

    Dinoprostone formulations Propess and Prostin E2 compared for labor induction safety and efficacy

    A study aims to compare the safety and efficacy of two dinoprostone formulations, Propess and Prostin E2, for inducing labor.

  31. 2024-01-01 ClinicalTrials.gov

    Oxytocin's Role in Eating Behavior, Glucose Metabolism, and Energy Expenditure Evaluated in Obesity

    This investigation into oxytocin's role in **obesity** could pave the way for novel therapeutic strategies targeting **appetite regulation**, **glucose homeostasis**, and **energy expenditure**. If future research reveals significant eff…

  32. 2026-07-29 ClinicalTrials.gov

    Sublingual Misoprostol Investigated for Enhanced Postpartum Hemorrhage Prevention Alongside Standard AMTSL

    Sublingual Misoprostol's potential to reduce postpartum hemorrhage when added to standard active management of third stage of labor (AMTSL) is being comparatively studied in low-risk parturients.

  33. 2026-07-29 ClinicalTrials.gov

    Uterine EMG-derived uSI to guide oxytocin dosing for labor induction and augmentation

    Developing a reliable **uterine stimulation index (uSI)** could revolutionize oxytocin administration during labor, moving towards a more objective and personalized approach. This could significantly reduce the incidence of **uterine hyp…

  34. 2026-07-29 ClinicalTrials.gov

    Oxytocin and Cognitive Bias Modification to be Investigated for Effects on Children's Maternal Trust

    Researchers plan to investigate how oxytocin and a cognitive bias modification (CBM) procedure influence children's trust in their mothers.

  35. 2026-07-29 ClinicalTrials.gov

    Oxytocin's Influence on Emotional Processing and Social Learning Under Investigation

    Oxytocin's role in influencing emotional processing and learning of social stimuli is the focus of this investigation, extending prior research.

  36. 2014-10-01 ClinicalTrials.gov

    PartoMa Project Aims to Strengthen Partogram-Based Labour Monitoring in East African Hospital

    PartoMa Project aims to strengthen `partogram`-based labour monitoring in an East African hospital, implementing guidelines and training to reduce **stillbirths** and **birth asphyxia**.

  37. 2025-11-20 ClinicalTrials.gov

    Semaglutide's Hypothesized Modulation of Epicardial Adipose Tissue Composition to Improve HFpEF Outcomes

    A study protocol aims to investigate if **semaglutide** shifts epicardial adipose tissue to a less proinflammatory profile and improves cardiovascular function in **HFpEF**.

  38. 2022-06-24 ClinicalTrials.gov

    rhGH therapy's effect on extracellular vesicles in GH-deficient children to be explored

    Study to evaluate rhGH therapy's impact on extracellular vesicle size and profile in children with GH deficiency.

  39. 2016-11-23 ClinicalTrials.gov

    Inhaled Oxytocin's Safety, Tolerability, and Drug Levels Compared to IM/IV for Post-Partum Hemorrhage

    **Developing a stable, inhaled oxytocin formulation could revolutionize PPH management**, especially in remote or under-resourced regions where cold chain and sterile injection supplies are scarce. This research directly addresses a crit…

  40. 2016-06-01 ClinicalTrials.gov

    Oxytocin's neurobiological mechanisms in trauma-induced intrusions to be explored in planned fMRI study

    Understanding the neurobiological mechanisms of oxytocin in trauma could significantly advance **PTSD prevention and treatment strategies**. If this planned study reveals how oxytocin modulates brain circuits involved in trauma processin…

  41. 2021-12-03 ClinicalTrials.gov

    Swiss real-world study to assess Saxenda® weight loss and treatment patterns in adults with obesity or overweight

    Understanding **Saxenda®'s** performance in real-world settings is critical for clinicians and patients, as controlled trials may not fully reflect diverse patient populations or adherence challenges. This chart-review study will provide…

  42. 2026-07-29 ClinicalTrials.gov

    Liraglutide Investigated for Reducing Epicardial Fat in Type 2 Diabetes Patients

    A withdrawn study aimed to assess **Liraglutide's** effect on epicardial fat in **Type 2 Diabetes** patients, a common issue linked to poor glycemic control.

  43. 2026-08-01 ClinicalTrials.gov

    Tirzepatide trial to evaluate reduction of atrial fibrillation recurrence in obese HFpEF patients

    Tirzepatide will be evaluated in a 602-participant trial for its ability to reduce atrial fibrillation recurrence after ablation in obese HFpEF patients.

  44. 2026-07-28 PubMed

    Sheep Milk Peptides FAWP, GPGGAW, FGER, and YPF Potently Inhibit Xanthine Oxidase, Offering Natural Hyperuricemia Management

    This discovery of potent **xanthine oxidase inhibitory peptides from sheep milk** offers a promising avenue for developing natural, safer alternatives for **hyperuricemia** management, potentially reducing reliance on synthetic drugs wit…

  45. 2026-07-28 PubMed

    GRPR-targeted radionuclide conjugates evolve from agonists to antagonists, enhancing tumor retention for cancer theranostics

    **This review provides a critical roadmap for the rational design of next-generation GRPR-targeted radiotheranostics**, offering invaluable insights for researchers, clinicians, and biohackers interested in advanced oncology applications…

  46. 2026-07-28 PubMed

    Correction Issued for Oral Semaglutide Effectiveness Pilot Study in Japanese Type 2 Diabetes

    **Readers should exercise caution when interpreting the original publication's conclusions** regarding oral semaglutide's effectiveness and predictive factors in Japanese T2DM patients. This correction highlights the critical importance …

  47. 2026-07-28 PubMed

    Review on Oral Peptide Delivery Strategies Corrected for Missing Citation

    A review on oral peptide and protein therapeutics delivery has received a formal correction for a missing citation, ensuring academic integrity.

  48. 2026-07-28 PubMed

    Recombinant ESAT6-MPT64 skin test safety, tolerability, and assay concordance evaluated in Phase 1 trial

    **Developing a safe and accurate recombinant ESAT6-MPT64 skin test could significantly improve tuberculosis diagnostics.** For clinicians, this could mean a more reliable and accessible screening tool than current methods, especially in …

  49. 2026-07-28 PubMed

    Peptide-drug conjugates emerge as a versatile strategy to overcome blood-brain barrier for CNS diseases

    This review underscores the transformative potential of **peptide-drug conjugates** (PDCs) for future CNS disease treatments. For clinicians and researchers, PDCs offer a pathway to deliver drugs that were previously ineffective due to B…

  50. 2016-02-11 ClinicalTrials.gov

    Somavaratan's long-term twice-monthly administration safety evaluated in adult growth hormone deficiency extension study.

    Establishing the long-term safety of **somavaratan** is paramount for its potential clinical adoption and for improving the treatment landscape for **AGHD** patients. Daily injections of conventional growth hormone can lead to significan…

  51. 2026-07-28 ClinicalTrials.gov

    Soy Isoflavones Investigated in Phase II Trial for Recurrent Prostate Cancer or Rising PSA

    If successful, **soy isoflavones** could offer a novel, non-pharmacological, and potentially well-tolerated dietary intervention for managing **recurrent prostate cancer** or rising **PSA**. This could provide patients with an additional…

  52. 2022-11-01 ClinicalTrials.gov

    Pulsed Electromagnetic Field (PEMF) therapy investigates muscle gain and pain relief in end-stage knee osteoarthritis with sarcopenia

    If successful, this trial could establish **Pulsed Electromagnetic Field (PEMF)** as a non-pharmacological, non-invasive intervention for **end-stage knee osteoarthritis** complicated by **sarcopenia**. This would offer a new therapeutic…

  53. 2026-09-01 ClinicalTrials.gov

    Lemborexant Pilot RCT to Assess Feasibility for Preventing Postoperative Delirium After Cardiac Surgery

    The successful completion of this pilot trial could **establish the feasibility of studying orexin receptor antagonists for POD prevention**, a critical unmet medical need. Given the high mortality and morbidity associated with **postope…

  54. 2019-02-01 ClinicalTrials.gov

    Oxytocin's potential to boost MRI-HIFU efficacy in patients to be evaluated in planned trial

    A planned randomized controlled trial will assess if oxytocin improves MRI-HIFU treatment efficacy, measuring patient symptoms and imaging data.

  55. 2022-01-01 ClinicalTrials.gov

    Intrauterine vs. Sublingual Misoprostol Routes Compared for Postpartum Blood Loss Prevention in Elective Cesarean Sections

    Optimizing **Misoprostol** administration routes could significantly impact **postpartum hemorrhage (PPH)** prevention protocols, particularly in settings where intravenous access is challenging or resources are scarce. Understanding whe…

  56. 2026-07-28 ClinicalTrials.gov

    In-Bed Exercise Program for Hospitalized High-Risk Pregnant Women Aims to Improve Well-being

    If successful, this in-bed exercise program could significantly **improve the physical and emotional well-being of high-risk pregnant women** undergoing bed rest. It offers a practical, low-cost intervention to counteract the negative co…

  57. 2025-09-22 ClinicalTrials.gov

    Mindfulness and meditation education investigated for impact on breastmilk in NICU mothers

    If mindfulness and meditation techniques are shown to positively influence maternal breastmilk production or composition in NICU mothers, this could **transform lactation support protocols** in critical care settings. Currently, interven…

  58. 2026-07-28 ClinicalTrials.gov

    Nipple Stimulation with Symphony PLUS® Breast Pump Explored for Labor Induction Efficacy and Acceptability

    Researchers are investigating if **nipple stimulation** using the **Symphony PLUS® breast pump** effectively induces labor by releasing endogenous oxytocin, and its acceptability.

  59. 2026-07-28 ClinicalTrials.gov

    Intranasal Oxytocin Hypothesized to Prevent PTSD Development by Facilitating Physiological Recovery Post-Trauma

    If the hypothesis is confirmed, a single, early administration of **intranasal oxytocin** could represent a groundbreaking prophylactic strategy for **PTSD**, especially for individuals in high-risk occupations or those who experience ac…

  60. 2026-07-28 PubMed

    CRMP2 emerges as central 'molecular switch' in chronic pain, targeted by novel non-opioid strategies

    **Targeting CRMP2 offers a paradigm shift towards non-opioid analgesics for chronic pain**, addressing the urgent need for safer and more effective treatments. This review consolidates evidence for CRMP2-based therapies, suggesting that …

  61. 2026-07-28 PubMed

    Systematic Review Details Melittin Modifications to Overcome Toxicity, Improve Stability, and Enable Targeted Delivery

    This review provides a critical roadmap for developing melittin into a viable therapeutic, moving beyond its current limitations as a toxic natural product. For peptide users and biohackers, understanding these modification strategies co…

  62. 2026-07-28 PubMed

    Mechanical Femoral Canal Opening During PFNA Fixation Increases Early Postoperative Inflammation and Organ Dysfunction

    Mechanical femoral canal opening during PFNA fixation significantly elevated postoperative inflammation, coagulation, and organ dysfunction markers compared to manual opening in elderly patients.

  63. 2026-07-28 PubMed

    Semaglutide Significantly Improves MASLD and MASH Severity in People with HIV

    **Semaglutide** is an effective treatment for **MASLD** in **people with HIV (PWH)**, a population with high morbidity and mortality from liver disease and limited treatment options. **Clinicians can now consider semaglutide as a viable …

  64. 2026-07-28 ClinicalTrials.gov

    Randomized Trial Compares Carbetocin and Oxytocin Hemodynamic Effects in Postpartum Women

    Understanding the distinct hemodynamic profiles of **carbetocin** and **oxytocin** is critical for optimizing uterotonic selection, especially in patients with pre-existing **cardiovascular disease**. If carbetocin demonstrates a more st…

  65. 2026-07-28 ClinicalTrials.gov

    Mathematical Model Proposed to Predict Growth Hormone Dose Adjustments Based on IGF-I Levels

    **A robust predictive model for GH dosing based on IGF-I levels could revolutionize patient care, particularly for children receiving growth hormone therapy.** Such a tool would provide clinicians with objective, data-driven guidelines, …

  66. 2024-10-28 ClinicalTrials.gov

    Intranasal oxytocin augments brief couples therapy for veteran PTSD, targeting symptoms and relationship quality.

    If successful, this trial could establish intranasal **oxytocin** as a valuable pharmacological adjunct to couples therapy for veterans with **PTSD**. **This could lead to significantly improved treatment protocols that not only reduce P…

  67. 2018-09-26 ClinicalTrials.gov

    Liraglutide 3mg (Saxenda) trial targets weight, body composition, and hormonal improvements in obese women with PCOS

    If successful, this trial could establish **Liraglutide 3mg** as a crucial pharmacologic intervention for obese women with **PCOS**, a population where weight loss is challenging and standard care often falls short. **Effective weight ma…

  68. 2026-07-28 ClinicalTrials.gov

    Liraglutide's Effects on Glucose Profiles and Gastric Emptying Investigated in Type 2 Diabetes

    Liraglutide's impact on glucose and hormonal profiles, fasting gluconeogenesis, insulin secretion, and gastric emptying was investigated in Type 2 Diabetes subjects.

  69. 2024-10-31 ClinicalTrials.gov

    HRS9531 undergoes Phase 3 evaluation against Semaglutide for Type 2 Diabetes management

    HRS9531 once weekly is being evaluated against Semaglutide once weekly for efficacy and safety in Type 2 Diabetes patients.

  70. 2025-06-02 ClinicalTrials.gov

    Semaglutide Pilot Trial Explores Cue-Reactivity and Safety in Opioid Use Disorder

    If **semaglutide** demonstrates positive effects on `cue-reactivity` or other efficacy measures, it could represent a novel adjunctive therapy for **opioid use disorder**, potentially improving outcomes for individuals undergoing bupreno…

  71. 2026-07-28 ClinicalTrials.gov

    GLP-1 Receptor Agonists to be Evaluated for Enhanced Rectal Cancer Response and Survival

    If this trial demonstrates improved outcomes, it could significantly alter the standard of care for **rectal cancer** patients with elevated **BMI**, integrating metabolic management directly into oncology protocols. **GLP-1 receptor ago…

  72. 2022-09-02 ClinicalTrials.gov

    Semaglutide shows robust therapeutic effects on alcohol use disorder in early-phase trial

    This early-phase trial offers compelling evidence that **semaglutide could be a viable therapeutic option for Alcohol Use Disorder (AUD)**, especially for individuals also managing obesity. For peptide users and clinicians, this suggests…

  73. 2017-10-19 ClinicalTrials.gov

    Tirzepatide's Efficacy, Safety, and Pharmacokinetics Investigated in Chinese and Japanese Type 2 Diabetes Patients

    Clinical trials evaluated **tirzepatide**'s safety, tolerability, pharmacokinetics, and efficacy in Chinese and Japanese patients with **Type 2 Diabetes**.

  74. 2026-07-28 PubMed

    AC02, a novel synthetic ACTH peptide, shows comparable pharmacodynamics to porcine ACTH1-39 for infantile spasms.

    AC02, a synthetic ACTH derivative, demonstrated favorable pharmacokinetics and free cortisol responses comparable to porcine ACTH1-39 in a first-in-human study.

  75. 2026-07-28 PubMed

    Rare sugars D-allulose and D-tagatose induce FGF21, curbing sugar/alcohol preference and preventing obesity/alcohol dependence in mice.

    This research suggests a **novel, food-based strategy for managing obesity and alcoholism** by leveraging the body's natural `FGF21` pathway. For biohackers and individuals seeking non-pharmacological interventions, incorporating rare su…

  76. 2026-07-28 PubMed

    2025 Ostheimer Lecture Highlights 13 Key Studies Reshaping Obstetric Anesthesia Practice

    The 2025 Ostheimer Lecture review summarizes 13 recent studies from 2024, offering practical findings to enhance safer, more effective obstetric anesthesia care.

  77. 2026-07-27 PubMed

    Accidental Tirzepatide Intradermal Injection Associated with Increased Adverse Events

    Accidental intradermal injection of **tirzepatide** was associated with an increase in adverse events compared to standard subcutaneous administration.

  78. 2026-07-27 PubMed

    Molecular Dynamics Reveals Distinct GLP-1R Binding and Activation Mechanisms for Semaglutide, Tirzepatide, Danuglipron, and CHU-128

    Molecular dynamics simulations of **semaglutide**, **tirzepatide**, **danuglipron**, and **CHU-128** reveal distinct GLP-1R binding and activation patterns influenced by temperature, ligand class, and signaling bias.

  79. 2026-07-27 ClinicalTrials.gov

    Low-dose Growth Hormone Investigated for Insulin Sensitivity, Steroid Metabolism in Obese PCOS Women

    **Elucidating the precise mechanisms by which low-dose GH influences insulin sensitivity and steroid metabolism in obese PCOS women could revolutionize therapeutic strategies.** If the study hypothesis is confirmed, this research could o…

  80. 2026-07-27 ClinicalTrials.gov

    IGF-I Administration Safety and Bone Marker Effects Explored in Adolescent Low Weight Girls

    A study aimed to determine the safety of Insulin Like Growth Factor-1 (IGF-I) administration and its impact on bone formation markers in adolescent low weight girls.

  81. 2026-07-27 ClinicalTrials.gov

    Somatropin growth hormone therapy investigated for accelerated intestinal healing in pediatric Crohn's disease

    If this trial demonstrates positive results, **somatropin growth hormone could become a valuable adjunctive therapy for pediatric Crohn's Disease**, specifically addressing the challenge of accelerating intestinal healing. This would rep…

  82. 2026-07-27 ClinicalTrials.gov

    rhIGF-1 (CEP-151) Phase II Pilot Study Assesses Tolerability and Effect on Brain Lesions in Multiple Sclerosis

    **rhIGF-1 (CEP-151) represents a potential novel therapeutic strategy for Multiple Sclerosis by directly targeting remyelination failure**, a critical aspect of progressive disability not adequately addressed by current immunomodulatory …

  83. 2026-07-27 ClinicalTrials.gov

    IGF-1 therapy for cystic fibrosis explored in 28-week pilot study targeting body weight and composition

    If **recombinant human IGF-1** demonstrates efficacy in improving body weight and composition in **Cystic Fibrosis** patients, it could represent a significant advancement in supportive care. This could lead to improved quality of life, …

  84. 2026-07-27 ClinicalTrials.gov

    Intranasal Oxytocin (40 IU) Investigated for Influence on Infidelity Tolerance in Males and Females

    A randomized study investigated if **intranasal oxytocin (40 IU)** influences the tolerance of infidelity in males and females.

  85. 2014-08-26 ClinicalTrials.gov

    Intranasal Oxytocin Investigated to Normalize Trust and Neural Processing in Borderline Personality Disorder

    A study aims to determine if **intranasal oxytocin** normalizes trust game performance and neural processing in **Borderline Personality Disorder** patients.

  86. 2026-07-27 ClinicalTrials.gov

    In Vitro Study Hypothesizes Oxytocin's Uterotonic Effect Weakens in Augmented Labor

    If the hypotheses are confirmed, this research could significantly refine clinical guidelines for managing **postpartum hemorrhage (PPH)**. **Understanding differential uterotonic efficacy based on prior oxytocin exposure could lead to p…

  87. 2020-04-01 ClinicalTrials.gov

    Oxytocin, Tranexamic Acid, and Carbetocin Compared for Postpartum Hemorrhage Prevention in Cesarean Sections

    This study aimed to evaluate oxytocin, tranexamic acid, and carbetocin for preventing postpartum hemorrhage during cesarean sections in at-risk patients.

  88. 2017-12-19 ClinicalTrials.gov

    Dilapan-S osmotic dilator compared to Dinoprostone for labour induction in 860 pregnant women

    If **Dilapan-S** proves as effective or superior to **Dinoprostone** with fewer side effects, it could significantly alter labour induction protocols, offering a non-pharmacological option that reduces the risk of uterine hyperstimulatio…

  89. 2014-04-29 ClinicalTrials.gov

    Intranasal Oxytocin Investigated for Emotion Regulation in Adolescents During Parental Disagreements

    If this study demonstrates positive effects, **intranasal oxytocin could emerge as a novel therapeutic adjunct for adolescents struggling with emotion regulation and family conflict**. Understanding how oxytocin modulates neural response…

  90. 2026-07-27 ClinicalTrials.gov

    Outpatient Foley catheter induction of labor investigated for efficacy and patient satisfaction in term pregnancies

    **Successful outpatient Foley catheter induction could transform labor induction protocols, offering a more patient-centric and resource-efficient approach.** It could reduce the burden on inpatient obstetric units and provide greater co…

  91. 2023-03-21 ClinicalTrials.gov

    CT-868's effects on glucose homeostasis in Type 1 Diabetes to be evaluated in new clinical study

    A clinical study is planned to assess CT-868's impact on glucose homeostasis in participants with **Type 1 Diabetes Mellitus**.

  92. 2021-07-16 ClinicalTrials.gov

    Liraglutide injection bioequivalence assessed in healthy Chinese subjects for pharmacokinetic and safety profiles

    Demonstrating bioequivalence for a new **Liraglutide** injection is a critical step towards making this important GLP-1 receptor agonist more widely available and potentially more affordable. **Successful bioequivalence would pave the wa…

  93. 2011-11-14 ClinicalTrials.gov

    Liraglutide and Insulin Real-World Use Evaluated for Quality of Life and Costs in Type 2 Diabetes

    **Understanding real-world effectiveness and cost-efficiency** of **Liraglutide** versus insulin is crucial for healthcare policy and patient choice in **Type 2 Diabetes**. This type of health service research helps clinicians and patien…

  94. 2026-07-30 ClinicalTrials.gov

    UBT251 Injection advances to Phase III, targeting Semaglutide non-inferiority in Type 2 Diabetes.

    UBT251 Injection begins Phase III trial to assess non-inferiority against Semaglutide for glycemic control in Type 2 Diabetes patients.

  95. 2024-12-20 ClinicalTrials.gov

    Exenatide implant's safety, tolerability, and drug levels assessed for sustained subcutaneous delivery

    While no specific results are provided, the *intent* of this study is highly significant for individuals managing **Type 2 Diabetes** or **obesity** with `GLP-1` receptor agonists. **A successful exenatide implant could revolutionize tre…

  96. 2026-11-01 ClinicalTrials.gov

    Metabolic Surgery shows potential to reduce Atrial Fibrillation severity and improve patient symptoms

    This research underscores the critical link between **obesity-related metabolic dysfunction** and **Atrial Fibrillation** (AF), suggesting a powerful therapeutic avenue beyond traditional cardiac interventions. For clinicians, it reinfor…

  97. 2026-07-27 PubMed

    Alpha-helix peptides self-assemble into VLNs, achieving 91% mRNA transfection and 93% siRNA knockdown.

    This study offers a highly promising, rationally designed approach to overcome major hurdles in **nucleic acid delivery**, which is crucial for advancing gene therapies. **The programmable nature of these α-helix peptide VLNs means futur…

  98. 2026-07-27 PubMed

    Histone H3K18 Lactylation Drives Perioperative Neurocognitive Disorder by Activating Microglial Pyroptosis via Lag3-NLRP3 Axis

    Microglial histone H3K18 lactylation (H3K18la) drives perioperative neurocognitive disorder (PND) by activating the Lag3-NLRP3 axis and triggering pyroptosis.

  99. 2026-07-26 PubMed

    [225Ac]Ac-PSMA-617 and rechallenge [177Lu]Lu-PSMA-617 evaluated against chemotherapy in mCRPC.

    [225Ac]Ac-PSMA-617 and rechallenge [177Lu]Lu-PSMA-617 were evaluated against cabazitaxel and metronomic cyclophosphamide for efficacy and toxicity in **66** mCRPC patients.

  100. 2026-07-26 PubMed

    Interleukin-40 levels serve as a treatment-sensitive marker in systemic sclerosis, not a disease activity indicator.

    Serum **IL-40** levels were significantly lower in immunosuppressed systemic sclerosis patients compared to untreated patients and controls, indicating treatment sensitivity.

Go deeper on one peptide